Anti-CHST3 monoclonal antibody

Pre-made anti-CHST3 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to CHST3/CHST3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0549-Ab-1/ GM-Tg-hg-IP0549-Ab-2Anti-Human CHST3 monoclonal antibodyHuman
GM-Tg-rg-IP0549-Ab-1/ GM-Tg-rg-IP0549-Ab-2Anti-Rat CHST3 monoclonal antibodyRat
GM-Tg-mg-IP0549-Ab-1/ GM-Tg-mg-IP0549-Ab-2Anti-Mouse CHST3 monoclonal antibodyMouse
GM-Tg-cynog-IP0549-Ab-1/ GM-Tg-cynog-IP0549-Ab-2Anti-Cynomolgus/ Rhesus macaque CHST3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0549-Ab-1/ GM-Tg-felg-IP0549-Ab-2Anti-Feline CHST3 monoclonal antibodyFeline
GM-Tg-cang-IP0549-Ab-1/ GM-Tg-cang-IP0549-Ab-2Anti-Canine CHST3 monoclonal antibodyCanine
GM-Tg-bovg-IP0549-Ab-1/ GM-Tg-bovg-IP0549-Ab-2Anti-Bovine CHST3 monoclonal antibodyBovine
GM-Tg-equg-IP0549-Ab-1/ GM-Tg-equg-IP0549-Ab-2Anti-Equine CHST3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0549-Ab-1/ GM-Tg-hg-IP0549-Ab-2; GM-Tg-rg-IP0549-Ab-1/ GM-Tg-rg-IP0549-Ab-2;
GM-Tg-mg-IP0549-Ab-1/ GM-Tg-mg-IP0549-Ab-2; GM-Tg-cynog-IP0549-Ab-1/ GM-Tg-cynog-IP0549-Ab-2;
GM-Tg-felg-IP0549-Ab-1/ GM-Tg-felg-IP0549-Ab-2; GM-Tg-cang-IP0549-Ab-1/ GM-Tg-cang-IP0549-Ab-2;
GM-Tg-bovg-IP0549-Ab-1/ GM-Tg-bovg-IP0549-Ab-2; GM-Tg-equg-IP0549-Ab-1/ GM-Tg-equg-IP0549-Ab-2
Products NameAnti-CHST3 monoclonal antibody
Formatmab
Target NameCHST3
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-CHST3 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0549-Ag-1Recombinant multi-species CHST3/ C6ST/ C6ST1 protein
    ORF Viral VectorpGMLPm004942mouse Chst3 Lentivirus plasmid
    ORF Viral VectorvGMLPm004942mouse Chst3 Lentivirus particle


    Target information

    Target IDGM-IP0549
    Target NameCHST3
    Gene ID9469,53374,84468,709333,100855759,101080828,506758,100063554
    Gene Symbol and SynonymsC6ST,C6ST-1,C6ST1,CHST3,GST-0,HSD
    Uniprot AccessionQ7LGC8,Q9QZL2
    Uniprot Entry NameCHST3_HUMAN,CHST3_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000122863
    Target ClassificationN/A

    The target: CHST3, gene name: CHST3, also named as C6ST, C6ST1, HSD. This gene encodes an enzyme which catalyzes the sulfation of chondroitin, a proteoglycan found in the extracellular matrix and most cells which is involved in cell migration and differentiation. Mutations in this gene are associated with spondylepiphyseal dysplasia and humerospinal dysostosis. [provided by RefSeq, Mar 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.